Developer of cancer diagnostic and personalized medicine technologies intended to improve early disease detection and treatment. The research organization performs molecular biological research on multiple cancer types, including bowel, breast, skin, blood, and cervical cancers. It operates a certified medical laboratory providing onco-genetic testing, genetic risk assessment, and metabolism analysis, serving healthcare and research sectors. The organization also engages in clinical trials utilizing digital health technologies and in-silico methods, collaborating with academic, medical, and industry partners.